FDA Inspection 1053558 — Novadigm Therapeutics Inc
The FDA completed an inspection of Novadigm Therapeutics Inc on May 15, 2018 in Lower Gwynedd, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 15, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lower Gwynedd, PA (United States)
Additional Details
Sponsor, Contract Research Organization